Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2020
September 03 2020 - 07:00AM
Amicus Therapeutics (Nasdaq: FOLD) today announced that members of
the Amicus senior leadership team will participate in upcoming
presentations at the following virtual investor conferences in
September:
- Citi’s 15th Annual BioPharma Virtual Conference on Thursday,
September 10, 2020 at 8:55 a.m. E.T.
- Cantor Virtual Global Healthcare Conference on Wednesday,
September 16, 2020 at 10:00 a.m. E.T.
- Bank of America Global Healthcare Conference on Friday,
September 18, 2020 at 4:45 p.m. B.S.T. (11:45 a.m. E.T.)
A live audio webcast of each presentation can be accessed via
the Investors section of the Amicus Therapeutics corporate website
at https://ir.amicusrx.com/events-and-presentations.
About Amicus Therapeutics
Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated
biotechnology company focused on discovering, developing and
delivering novel high-quality medicines for people living with rare
metabolic diseases. With extraordinary patient focus, Amicus
Therapeutics is committed to advancing and expanding a robust
pipeline of cutting-edge, first- or best-in-class medicines for
rare metabolic diseases. For more information please visit the
company’s website at www.amicusrx.com, and follow on Twitter and
LinkedIn.
CONTACT:
Investors: Amicus Therapeutics Andrew Faughnan
Director, Investor Relations afaughnan@amicusrx.com(609)
662-3809
Media: Amicus Therapeutics Diana Moore Head of
Global Corporate Communications dmoore@amicusrx.com(609)
662-5079
FOLD–G
Amicus Therapeutics (NASDAQ:FOLD)
Historical Stock Chart
From Feb 2024 to Mar 2024
Amicus Therapeutics (NASDAQ:FOLD)
Historical Stock Chart
From Mar 2023 to Mar 2024